RE:RE:RE:Flu virus augment vaccines In your estimation, are the indications concerning Pela, equal to or ahead of Candel which has achieved a Fast Track designation from the FDA. Ya know,in terms of survival rate and other comparable positive results or are they both on opposite tracks to treatment and success? Just trying to gain a little insight into the science because with the lack of prior successes in treatment of Pancreatic C combined with the Steady increase in cases....it does appear to be a real race to be the most significant and likely candidate for first line treatment. Hope, I am making sense or am I just being redundant?
Happy New Year to All